The impact of medicinal treatment on quality of life in inflammatory bowel diseases: experience with the IBDQ questionnaire
Objective: To evaluate quality of life in patients with inflammatory bowel disease. Materials and methods: A prospective cross-sectional study involving 46 patients was conducted with outpatient follow-up. Results: Crohn’s disease was present in 32 (69.6%) of the total number of patients assessed (n = 46), and ulcerative colitis in 14 (30.4%). Of these patients, 25 (54.3%) were women and 21 (45.7%) were men. The mean patient age was 47.3 years. Non-smokers comprised 95.7% of participants. A history of surgery for the primary disease was noted in 11 patients (23.9%). Twenty (43.5%) patients received combination therapy, 21 (45.7%) received monotherapy, and the remaining five (10.9%) did not receive medical treatment. Significant improvement in quality of life was observed among patients treated with metipred. Conclusions: Patients who received Metipred had the highest quality of life scores. No other statistically significant correlations with quality of life were found.
Сведения
- Опубликовано
- 2025 · № 3, С. 60-66
- Язык
- Английский
- ISSN
- 0514-2415
- Издатель
- МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОЙ ЗАЩИТЫ НАСЕЛЕНИЯ РЕСПУБЛИКИ ТАДЖИКИСТАН
- Аффилиации
- Department of Internal Medicine N.3, SEI Avicenna Tajik State Medical University